Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07216885Not ApplicableRecruiting

Solv Multi-Pass Hemodialysis System In-Center Clinical Study

Role: lead

NCT04608149Active Not Recruiting

Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study.

Role: lead

NCT04395131Not ApplicableCompleted

Clearum High Flux Hemodialyzer Used in Hemodialysis for Subjects With End-Stage Renal Disease

Role: lead

NCT05161078Enrolling By Invitation

Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration

Role: collaborator

NCT05927532Not ApplicableCompleted

Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study

Role: lead

All 5 trials loaded